Scilex Holding (NASDAQ:SCLX – Get Rating)’s share price gapped up before the market opened on Friday . The stock had previously closed at $7.45, but opened at $7.84. Scilex shares last traded at $6.95, with a volume of 35,905 shares changing hands.
Scilex Stock Up 6.0 %
The stock’s 50-day moving average is $8.16.
Institutional Trading of Scilex
Several large investors have recently bought and sold shares of SCLX. UBS Group AG bought a new stake in shares of Scilex in the 4th quarter worth approximately $29,000. Millennium Management LLC bought a new stake in shares of Scilex in the 4th quarter worth approximately $45,000. Finally, Geode Capital Management LLC bought a new stake in shares of Scilex in the 4th quarter worth approximately $47,000. 72.74% of the stock is owned by institutional investors.
Scilex Company Profile
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain.
Featured Stories
- Get a free copy of the StockNews.com research report on Scilex (SCLX)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
